Drug trialled at city hospital ‘should be less expensive’

Health news
Health news
Have your say

The manufacturer of a breast cancer drug trialled in Sheffield has been urged to reduce the treatment’s price - after it was rejected for wider NHS use on cost grounds.

The drug Kadcyla, made by Roche, can extend some patients’ lives by six months, but is currently priced at £90,000. It was tested at Weston Park Hospital.

Sir Andrew Dillon, chief executive of NHS rationing body NICE, said Roche should ‘do more’ to make Kadcyla available.